How Real-World Data (RWD) Is Transforming Clinical Trials ?
Real-world data clinical trials are not a workaround but are a design upgrade. The traditional controlled trial model: controlled populations, site-based enrollment, manual review, built clear evidence slowly and at high cost , from populations that represented a narrow slice of those who actually take the drug, and the FDA recognized that gap. Pharma organizations building evidence programs around RWD generate faster data, at lower cost, from populations that look like the real patient population. The ones still running site-only trials are paying for constraints they no longer have to accept. The cost difference is not marginal. Site-based enrollment for a Phase III program runs on years of referral chains, travel requirements, and geographic exclusions that systematically underrepresent rural and minority populations. RWD cuts those constraints. The trial runs on patients who already exist in the health system data. What Is Real-World Data in Healthcare? Re...
